Skip to content
AnalystLens

Charles River Laboratories International 8-K Report, Executive Changes (May 23, 2025)

Reports
Leadership Changes·Shareholder Matters
Filing Date
Filed May 23, 2025
Period End
May 20, 2025
Security
CRL
In the record · 2016–202610-K1110-Q338-K117

CRL filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 117 current reports (8-K) between 2016 and 2026.

  1. Deal closed8-K · Apr ’18Apr ’18
  2. Material agreement8-K · Oct ’19Oct ’19
  3. Leadership change8-K · Mar ’22Mar ’22
  4. Leadership change8-K · May ’26May ’26

Summary

Summary of the 8-K filed May 23, 2025. Cited figures are marked; the original filing is the authoritative source.

Charles River Laboratories International, Inc. filed this Current Report on Form 8-K to disclose two matters: an employment agreement amendment for its Chair, President and Chief Executive Officer, and the results of its 2025 Annual Meeting of Shareholders held on May 20, 2025.

On May 20, 2025, the Company and James C. Foster entered into Amendment No. 1 to his Amended and Restated Employment Agreement dated May 18, 2021. The amendment extends his employment term by one year, to February 12, 2027, and leaves all other terms unchanged.

The Company states that the full amendment will be filed as an exhibit to its Quarterly Report on Form 10-Q for the second quarter of fiscal 2025. At the Annual Meeting, shareholders elected seven directors to serve until the 2026 Annual Meeting. Mr. Foster received 39,676,718 votes for and 1,908,059 against, while the other six nominees each received more than 40 million votes for.

Shareholders approved, on an advisory basis, the compensation of the named executive officers, with 40,218,870 votes for, 1,432,240 against and 102,252 abstaining. Shareholders also ratified PricewaterhouseCoopers LLP as independent auditors, with 42,348,057 votes for and 1,551,238 against. A shareholder proposal submitted by PETA to publish a report on non-human primates imported by the Company was not approved, receiving 3,457,547 votes for and 38,051,509 against.

Board composition also changed. Robert Bertolini, Deborah T. Kochevar, George E.

Massaro and Richard F. Wallman did not stand for re-election after their terms expired, as previously disclosed in a Form 8-K filed May 7, 2025. On May 20, 2025, the Board appointed Steven Barg, Mark Enyedy, Abraham Ceesay and Paul Graves to fill the resulting four vacancies, each with a term expiring at the 2026 Annual Meeting.

Key Highlights

  1. Chair, President and CEO James C. Foster's employment term was extended by one year, to February 12, 2027, under Amendment No. 1 signed May 20, 2025; all other terms are unchanged.
  2. Seven directors were elected to serve until the 2026 Annual Meeting, with Mr. Foster receiving 39,676,718 votes for and 1,908,059 against.
  3. Four new directors were appointed by the Board on May 20, 2025: Steven Barg, Mark Enyedy, Abraham Ceesay and Paul Graves.
  4. Directors Robert Bertolini, Deborah T. Kochevar, George E. Massaro and Richard F. Wallman did not stand for re-election, creating four Board vacancies.
  5. Shareholders approved the advisory say-on-pay proposal, with 40,218,870 votes for and 1,432,240 against.
  6. Shareholders ratified PricewaterhouseCoopers LLP as independent auditors, with 42,348,057 votes for and 1,551,238 against.
  7. A PETA shareholder proposal on a report regarding non-human primates imported by the Company was not approved, with 38,051,509 votes against.

Frequently Asked Questions

  1. What changed in James C. Foster's employment agreement?

    Amendment No. 1, entered into May 20, 2025, extends the term of Mr. Foster's employment by one additional year, until February 12, 2027. The filing states that all other terms and conditions of his Amended and Restated Employment Agreement dated May 18, 2021, remain unchanged. The full amendment will be filed as an exhibit to the Company's Form 10-Q for the second quarter of fiscal 2025.

  2. Who joined the Board of Directors, and who left?

    The Board appointed Steven Barg, Mark Enyedy, Abraham Ceesay and Paul Graves on May 20, 2025, each with a term expiring at the 2026 Annual Meeting. Robert Bertolini, Deborah T. Kochevar, George E. Massaro and Richard F. Wallman did not stand for re-election after their terms expired, as previously disclosed in a Form 8-K filed May 7, 2025.

  3. Did shareholders support management's proposals at the Annual Meeting?

    Shareholders elected all seven nominees, approved the advisory say-on-pay proposal with 40,218,870 votes for and 1,432,240 against, and ratified PricewaterhouseCoopers LLP as independent auditors with 42,348,057 votes for and 1,551,238 against. The filing lists the auditor ratification as covering fiscal 2024.

  4. What was the outcome of the PETA shareholder proposal?

    Shareholders did not approve the proposal submitted by PETA to publish a report on non-human primates imported by the Company. The vote was 3,457,547 for, 38,051,509 against and 244,306 abstaining, with 2,209,405 broker non-votes.